View Single Post
Old 05-24-2013, 01:55 PM   #4
GenoMax
Senior Member
 
Location: East Coast USA

Join Date: Feb 2008
Posts: 6,814
Default

There is no doubt that unused sequencing capacity exists but there are two facets to that question. For consumers: how to tap into it productively and simply? For providers: How to accurately estimate the spare capacity and make it available "just in time"?

At many universities items like sequencers are purchased from capital expenditure funds meant to boost infrastructure capacity for internal needs. As a result internal samples always have priority. We run a mix of several HiSeq/MiSeq and there are (rare) times when a machine or two idles for a length of time. We had thought about using that time but since we can't accurately predict the availability it was not very practical.

Most commercial customers are looking for sustained availability/capacity over a length of defined time, on the other hand dealing with small infrequent samples is not worth the logistics involved in handling/billing/delivery of data.
GenoMax is offline   Reply With Quote